These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37663876)

  • 1. The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma - A targeted literature review.
    Albanna AS; Alhajji M; Alsowayan W; Soliman MH
    Ann Thorac Med; 2023; 18(3):103-115. PubMed ID: 37663876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An innovative corticosteroid/long-acting β
    Usmani O; Roche N; Marshall J; Danagher H; Price D
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Response and Cost-Savings Associated With Generic Fluticasone Propionate/Salmeterol Multidose, Dry-Powder Inhaler in Asthma Patients Managed in an Ambulatory Care Practice Setting.
    McCarthy P; Iliadis T; Zaiken K
    J Pharm Pract; 2022 Apr; 35(2):274-280. PubMed ID: 33161797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA.
    Park HS; Yoon D; Lee HY; Ban GY; Wan Yau Ming S; Jie JLZ; Carter V; Hardjojo A; Van Boven JFM; Price DB
    Respirology; 2019 Oct; 24(10):972-979. PubMed ID: 31038269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI).
    Al-Ahmad M; Webb D
    Respir Med; 2022 Apr; 194():106771. PubMed ID: 35180515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
    Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
    Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation.
    Müller V; Gálffy G; Eszes N; Losonczy G; Bizzi A; Nicolini G; Chrystyn H; Tamási L
    BMC Pulm Med; 2011 Jul; 11():40. PubMed ID: 21762500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost saving of switching to equivalent inhalers and its effect on health outcomes.
    Bloom CI; Douglas I; Olney J; D'Ancona G; Smeeth L; Quint JK
    Thorax; 2019 Nov; 74(11):1078-1086. PubMed ID: 31383774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA.
    Wang Z; Ahluwalia SK; Newman B; Dhapare S; Zhao L; Luke MC
    Ther Innov Regul Sci; 2022 Mar; 56(2):346-357. PubMed ID: 35118630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma.
    Dunlop W; Heron L; Fox G; Greaney M
    Adv Ther; 2013 Oct; 30(10):933-44. PubMed ID: 24194361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in asthma--fixed or variable dosing in different patients?
    Lötvall J
    Curr Med Res Opin; 2004 Nov; 20(11):1711-27. PubMed ID: 15537472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients.
    Price D; Thomas V; von Ziegenweidt J; Gould S; Hutton C; King C
    J Asthma Allergy; 2014; 7():31-51. PubMed ID: 24748807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its mono-components, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma.
    Mehta N; Aggarwal B; Gogtay J; Abdool-Gaffar S
    Expert Opin Drug Deliv; 2015 Jun; 12(6):963-75. PubMed ID: 25429610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.